Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison. (Q40561453)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 April 2003

Language	Label	Description	Also known as
English	Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.	scientific article published on 11 April 2003

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

M Gorschlüter

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Hahn

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Fixson

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

U Mey

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Ziske

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Horré

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Sauerbruch

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Marklein

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

I G H Schmidt-Wolf

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Glasmacher

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

11 April 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Supportive Care in Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

362-370

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12690546%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

https://scigraph.springernature.com/pub.10.1007/s00520-003-0463-7

0 references

Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftriaxone and Amikacin versus Ceftazidime and Amikacin in Febrile Granulocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftriaxone plus conventional or single-daily dose amikacin versus ceftazidime/amikacin as empiric therapy in febrile neutropenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftriaxone versus beta-lactams with antipseudomonal activity for empirical, combined antibiotic therapy in febrile neutropenia: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia i

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of tazobactam on the frequency of the emergence of resistant strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (beta-lactamase derepressed mutants)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Piperacillin-tazobactam as empiric monotherapy in febrile neutropenic patients with haematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of suppression of piperacillin resistance in enterobacteria by tazobactam

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Piperacillin/tazobactam in the treatment of polymicrobial infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

1 reference

https://pubmed.ncbi.nlm.nih.gov/12690546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40561453&oldid=1584823720"